Health Care Equipment

Myomo

Myomo released FY2025 9 Months earnings on November 10 After-Market (EST), actual revenue USD 29.57 M, actual EPS USD -0.31

Myomo released FY2025 Q3 earnings on November 10 After-Market EST, actual revenue USD 10.09 M (forecast USD 9.438 M), actual EPS USD -0.0868 (forecast USD -0.108)

Myomo Inc. Secures $17.5 Million Loan to Support Operations

Myomo to Release FY2025 Q3 Earnings on November 10 After-Market (EST), Forecast Revenue USD 9.438M, EPS USD -0.108

Myomo released FY2025 Semi-Annual Earnings on August 11 After-Market (EST), actual revenue USD 19.48 M, actual EPS USD -0.2143

Myomo released FY2025 Q2 earnings on August 11 After-Market EST, actual revenue USD 9.652 M (forecast USD 9.147 M), actual EPS USD -0.1113 (forecast USD -0.106)

Myomo to Release FY2025 Q2 Earnings on August 11 After-Market EST, Forecast Revenue USD 9.147 M, EPS USD -0.106

Craig-Hallum Maintains Buy Rating on Myomo and Cuts Price Target

Myomo Inc. Holds Investor and Analyst Day Event

Ascendiant Capital Maintains Myomo Buy Rating and Raises Price Target

Craig-Hallum Maintains Myomo Buy Rating and Adjusts Price Target Down

Myomo released FY2025 Q1 earnings on May 7 After-Market EST, actual revenue USD 9.832 M (forecast USD 9.221 M), actual EPS USD -0.1006 (forecast USD -0.076)

Myomo Inc. Reports Q1 2025 Revenue Growth of 162% to $9.8 Million

Myomo to Host First Investor and Analyst Day

Myomo Launches MyoPro 2x Wearable Medical Device

Myomo to release FY2025 Q1 earnings on May 7 After-Market EST, forecast revenue USD 9.221 M, EPS USD -0.076

Two Board Members of Myomo, Inc. Will Not Seek Re-election

Myomo Reports Q4 2024 Financial Results, Revenue Exceeds Expectations, Faces Long-term Risks

Myomo released FY2024 Q4 earnings on March 10 After-Market (EST), actual revenue $12.07M (forecast $9.898M), actual EPS -$0.0066 (forecast -$0.0233)

Myomo released FY2024 annual earnings on March 10 After-Market EST, actual revenue 32.55 M USD (forecast 30.39 M USD), actual EPS -0.1637 USD (forecast -0.18 USD)

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

Delcath

Electromed

Abbott Laboratories

Intuitive Surgical

Boston Scientific

Stryker

IDEXX Labs

Edwards Lifesciences

Resmed

DexCom

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap